3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Breast Neoplasms
3
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Spondylitis, Ankylosing
1
Smoking Cessation
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Mental Disorders
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Leukemia, Myeloid, Acute
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Depressive Disorder
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Non-Small-Cell Lung
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Reactive
1
Arthritis, Psoriatic
1
Advanced Malignant Solid Neoplasm
1
Interventions
pembrolizumab
14
Paclitaxel
14
Carboplatin
12
Bevacizumab
7
Specimen Handling
6
Cisplatin
6
olaparib
5
Taxes
5
Fulvestrant
5
Nivolumab
4
Megestrol Acetate
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
Biopsy
4
palbociclib
3
durvalumab
3
Oxaliplatin
3
Leucovorin
3
Letrozole
3
Immunoglobulin G
3
Gemcitabine
3
Fluorouracil
3
Docetaxel
3
Disulfides
3
trastuzumab deruxtecan
2
ribociclib
2
pertuzumab
2
lenvatinib
2
ipatasertib
2
dostarlimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Interviews as Topic
×
30 days
×
Clear all
No trials found.